{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-004766","form_type":"8-K","ticker":"ACTU","cik":"0001652935","company_name":"ACTUATE THERAPEUTICS, INC.","filed_at":"2025-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.213736+00:00","generated_at":"2026-05-18T17:57:09.181190+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Actuate Therapeutics raises ~$4.7M in private placement of common stock and warrants","bullets":["Gross proceeds of approx. $4.7M from sale of 666,497 shares at $7.00/share and warrants to purchase 666,497 shares.","Warrants exercisable at $7.00 for 20 days after Milestone Date (FDA Breakthrough Therapy or registration determination for elraglusib).","Bios 2024 Co-Invest, LP (affiliated with Chairman Dr. Aaron G.L. Fletcher) purchasing 71,428 shares and warrants for ~$500K.","Closing expected on or before June 30, 2025; proceeds for working capital and general corporate purposes.","Registration rights agreement requires filing resale registration statement by August 9, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-004766","json":"https://secwatch.observer/filing/0001683168-25-004766.json","markdown":"https://secwatch.observer/filing/0001683168-25-004766.md","text":"https://secwatch.observer/filing/0001683168-25-004766.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825004766/0001683168-25-004766-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825004766/actuate_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T17:57:09.181190+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}